netFormulary NHS
Birmingham, Sandwell, Solihull and environs APC Formulary
Maintained by Midlands and Lancashire Commissioning Support Unit
 Search
 Formulary Chapter 26: A5 - Wound management products and elasticated garments - Full Chapter
Notes:

 Please note: silk garments are non-formulary

Chapter Links...
 Details...
A5.01  Basic wound contact dressings
A5.01.01  Low adherence dressings
Atrauman
View adult BNF View SPC online View childrens BNF
First Choice
Green
Type of wound product is suitable for
For flat granulating and epithelising wound for non to heavy exudate where adherence may occur. To be used as a primary dressing with a secondary for absorption.

Duration dressing remains on wound before changing
Up to 7 days

Frequency of dressing change
1-7 days, depending on levels of exudate

Caution/contraindications (when not to use the dressing, patient groups to avoid etc.
Known product or component sensitivity

Rationale for inclusion in formulary
Used to reduce adherence to wound bed. Most cost effective non adherent dressing.
Dressing impregnated with neutraltriglycerides to prevent penetration of granulation tissue.
Petroleum free.
 
N/A Ultra
View adult BNF View SPC online View childrens BNF
Second Choice
Green
Type of wound product is suitable for
For flat granulating and epithelising wound for non to heavy exudate levels where
adherence may occur. To be used as a primary dressing with a secondary for absorption.

Duration dressing remains on wound before changing
7 days maximum

Frequency of dressing change
1-7 days, depending on levels of exudate

Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
Known product or component sensitivity eg silicone
Use with care if wound is bleeding heavily

Rationale for inclusion in formulary
To be used to reduce adherence to wound bed
 
   
A5.01.02  Absorbent dressings
A5.01.02  For lightly exuding wounds
Softpore - self adhesive
(alternative to Cosmopore)
View adult BNF View SPC online View childrens BNF
First Choice
Green
Type of wound product is suitable for
Low to moderately exuding wounds, superficial wounds (closed), light amounts of
exudate.
Use alone without other products, also can be used as a protective dressing for sutured
post operative wounds. Can be used as a protective dressing for newly epithelialised wounds. Can be used for minor traumatic wounds

Duration dressing remains on wound before changing
Maximum 7 days, dependent on exudate levels

Frequency of dressing change
If daily change is required; review dressing type

Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
Known product or component sensitivity

Rationale for inclusion in formulary
Sutured/Post-surgical wound for protection . Most cost effective option.
Can be used as a protective dressing for newly epithelialized wounds. Can be used for minor traumatic wounds
 
Mepore
View adult BNF View SPC online View childrens BNF
Second Choice
Green
Type of wound product is suitable for
Post operative closed surgical wounds or simple wounds with up to light amounts of exudate.
Can be used as a protective dressing for sutured post operative wounds. Can be used as a protective dressing for newly epithelialized wounds. Can be used for small traumatic wounds.

Duration dressing remains on wound before changing
Up to 7 days

Frequency of dressing change
1-7 days. If daily change is required - review product choice

Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
Known product or component sensitivity

Rationale for inclusion in formulary
Sutured surgical wounds for protection. Can be used as a protective dressing for newly epithelialized wounds. Can be used for small traumatic wounds. 
   
Telfa
(Podiatry only )
View adult BNF View SPC online View childrens BNF
Formulary
Green
Thin absorbent cotton pad with non adherent film

Type of wound product is suitable for
Dry or lightly exuding wounds

Duration dressing remains on wound before changing
1-7 days

Frequency of dressing change
As exudate levels determines

Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
None

Rationale for inclusion in formulary
Cost effective. Non adherent dressing for dry or lightly exuding wounds
 
   
A5.01.02  For moderately to heavily exuding wounds to top
Zetuvit E
(sterile and non-sterile)
View adult BNF View SPC online View childrens BNF
Formulary
Green
Absorbent cellulose pad with fluid repellent backing

Type of wound product is suitable for
Moderate exuding wounds . Secondary dressing.
Available in non sterile and sterile.
Only sterile to be used for wound care.

Duration dressing remains on wound before changing
1-7 days

Frequency of dressing change
Usually 1-2 days or when wet. If using daily consider Zetuvit Plus

Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
Known product or component sensitivity
Do not cut or tear

Rationale for inclusion in formulary
Required for absorbency, for moderately exuding wounds
Step down from Zetuvit Plus
 
   
Zetuvit PLUS
View adult BNF View SPC online View childrens BNF
Formulary
Green
Super absorbent dressing

Type of wound product is suitable for
Moderate to heavily exuding acute and chronic wounds. Secondary dressing only

Duration dressing remains on wound before changing
1-7 days

Frequency of dressing change
1-3 days, if changing daily, review if needs more highly absorbent dressing, if lasting 7
days step down to Zetuvit E

Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
Do not use if sensitivity to dressing or components
Do not cut or tear

Rationale for inclusion in formulary
Moderate to heavily exuding wounds, higher absorbency than Zetuvit E. Cost effective.
 
   
A5.01.02  For heavily exuding wounds
Eclypse
View adult BNF View SPC online View childrens BNF
Formulary
Green

Approved June 2018 to replace Flivasorb®

 
   
KerraMaxCare
View adult BNF View SPC online View childrens BNF
Formulary
Red
Superabsorbent dressing
Type of wound product is suitable for
Highly exuding wounds as a primary or secondary dressing. Can be used under compression therapy
Stackable as no backing present to hold exudate

Duration dressing remains on wound before changing
1-7 days.
Frequency of dressing change
Dependent on level of exudate, usually daily or more frequently
Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
Do not cut or tear
Rationale for inclusion in formulary
Required for heavily exuding wounds. Hospital Use Only
 
   
A5.02  Advanced wound dressings
A5.02.01  Hydrogel dressings
A5.02.01  Hydrogel application (amorphous)
AquaForm
(alternative to Granugel)
View adult BNF View SPC online View childrens BNF
Formulary
Green
Hydrogel: Clear viscose sterile gel
Aids autolytic debridement and removal of devitalised tissue.

Type of wound product is suitable for
Low exuding, necrotic or sloughy wounds

Duration dressing remains on wound before changing
Up to 3 days

Frequency of dressing change
1-3 days

Caution/contraindications (when not to use the dressing, patient groups to avoid etc.) Not suitable for heavily exuding wounds. Caution known product or component sensitivity.
Full thickness burns or infected wounds
Not for application to ischaemic wounds

Rationale for inclusion in formulary
Required for wound beds that need donation of moisture to rehydrate the wound bed and debride. Cost effective
 
   
A5.02.01  Hydrogel sheet dressings to top
ActiForm Cool
View adult BNF View SPC online View childrens BNF
Formulary
Green
Hydrogel Sheet
Type of wound product is suitable for
Necrotic or sloughy wounds that require hydration and cooling pain relief
Can be used on dry wounds with the backing left in place
Cut to shape of the wound
Requires a secondary dressing
Duration dressing remains on wound before changing
1-3 days if dressings become discoloured or opaque or at first signs of exudate strike
through
Frequency of dressing change
If dressing becomes discoloured or opaque or at first signs of exudate strike through. Do not allow to dry out
Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
Should not be used as a covering for deep narrow cavities or sinuses. Do not use on infected wounds.
Not suitable for heavily exuding wounds Known product or component sensitivity Not for application on ischaemic wounds
Rationale for inclusion in formulary
Dry necrotic, sloughy or painful wounds
For ease of application - sheet gel rather than liquid
Primary dressing
Can be used prior to larval therapy to maintain moisture levels
 
   
A5.02.01.01  Sodium hyaluronate dressings
A5.02.02  Vapour-permeable films and membranes
A5.02.02  Vapour-permeable Adhesive Film Dressing (Semi-permeable Adhesive Dressing)
Hydrofilm
View adult BNF View SPC online View childrens BNF
First Choice
Green
Vapour-permeable adhesive film

Type of wound product is suitable for
Dry non infected wounds, retention of lines, fixation of secondary dressings, protection of intact skin, protection of skin against friction, protection of newly epithelialized wounds

Duration dressing remains on wound before changing
Up to 7 days

Frequency of dressing change
Up to 7 days

Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
Clinically infected wounds, bleeding or exuding wounds

Rationale for inclusion in formulary
Retention of lines, protection of intact skin, fixation of other dressings. Cost effective
Waterproof
 
C View
View adult BNF View SPC online View childrens BNF
Second Choice
Green
Vapour-permeable adhesive film

Type of wound product is suitable for
Dry non infected wounds, retention of lines, fixation of secondary dressings, protection of intact skin, protection of skin against friction, protection of newly epithelialized wounds

Duration dressing remains on wound before changing
Up to 7 days

Frequency of dressing change
Up to 7 days

Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
Clinically infected wounds, bleeding or exuding wounds

Rationale for inclusion in formulary
Retention of lines, protection of intact skin, fixation of other dressings. Waterproof
 
   
A5.02.02  Vapour-permeable Adhesive Film Dressing with absorbent pad
C-View Post-Op
View adult BNF View SPC online View childrens BNF
Formulary
Green
Vapour-permeable adhesive film with absorbent pad
Type of wound product is suitable for
Dry non infected wounds, low exuding wounds, minor burns, protection of intact skin, protection of newly epithelialized wounds
Duration dressing remains on wound before changing
Up to 7 days
Frequency of dressing change
Up to 7 days
Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
Clinically infected wounds, bleeding or exuding wounds
Rationale for inclusion in formulary Protection of intact skin, low exuding wounds. Waterproof
 
   
A5.02.02  For intravenous and subcutaneous catheter sites to top
IV 3000
View adult BNF View SPC online View childrens BNF
Formulary
Amber
Fixation dressing
Type of wound product is suitable for
For fixation of intravenous and subcutaneous catheter sites
Duration dressing remains on wound before changing
Up to 7 days
Frequency of dressing change
Up to 7 days or when wet/soiled
Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
Sensitivity to any of the product components
Not for use on pressure ulcers, burns or donor sites
Strips and documentation label are not to be used as suture replacements or primary wound closure methods
Rationale for inclusion in formulary
Fixation of intravenous and subcutaneous devices
 
   
A5.02.03  Soft polymer dressings
A5.02.03  Without absorbent pad
Urgotul
View adult BNF View SPC online View childrens BNF
Formulary
Green
A non-adherent flexible wound contact layer containing TLC Healing Matrix.

Type of wound product is suitable for
Non to low exuding wounds, dermabrasions, traumatic, superficial, blistering. Can be
used as a contact layer in cavity wounds with secondary absorbent dressing. Difficult to dress
areas – fingers and toes.

Duration dressing remains on wound before changing
Up to 7 days

Frequency of dressing change
Depends on clinical needs up to 7 days

Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
Known sensitivity to any components

Rationale for inclusion in formulary
Pain free dressing changes. Promotes healing, interactive. Cost effective. Large range of sizes available
 
   
Mepitel
View adult BNF View SPC online View childrens BNF
Formulary
Amber
Soft polymer non-adherent dressing without pad

Type of wound product is suitable for
Primary wound contact layer, non adherent, traumatic and chronic wounds
Requires secondary dressing

Duration dressing remains on wound before changing
Up to 7 days

Frequency of dressing change
Up to 7 days

Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
Heavily bleeding wounds
Any sensitivity to silicone

Rationale for inclusion in formulary
Non-adherent primary wound contact layer to protect skin tears, fragile skin, primary contact layer for use under topical negative pressure


 
   
A5.02.03  With absorbent pad
Allevyn Life
View adult BNF View SPC online View childrens BNF
Formulary
Amber
Hydrocellular foam dressing
Type of wound product is suitable for
Shallow granulating wounds, acute and chronic exuding wounds, full and partial thickness wounds
such as leg ulcer, malignant wound, surgical wound. Primary dressing
Silicone adhesive
Duration dressing remains on wound before changing
Up to 7 days dependent on dressing indicators
Frequency of dressing change
Up to 3 times a week maximum
Caution/contraindications (when not to use the dressing, patient groups to avoid etc.) Do not use with oxidising agents such as hypochlorite solutions or hydrogen peroxide Discontinue if reddening or sensitivity occurs.
Do not cut
Caution under compression where exudate levels are moderate to high
Rationale for inclusion in formulary
Fragile skin with absorbency and conformability, problematic healing wounds. Odour control.
 
   
kliniderm Foam Silicone
View adult BNF View SPC online View childrens BNF
Formulary
Amber
  • November 2016: approved for use, replacing Mepilex®

    Polyurethane foam with adhesive silicone wound contact layer

    Type of wound product is suitable for
    Suitable for acute and chronic wounds including leg ulcers, pressure ulcers, superficial and partial thickness burns, donor sites, post operative wounds and skin abrasions. Suitable for low to moderately exuding wounds for patients with fragile skin
    Available in border and non border

    Duration dressing remains on wound before changing
    Up to 7 days

    Frequency of dressing change
    1-7 days – dependant on exudate level

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Known product or component sensitivity eg Silicone

    Rationale for inclusion in formulary
    Wound contact surface is coated with a layer of soft silicone which reduces trauma to delicate tissue. Range of shapes and sizes available.
     
  •    
    A5.02.03  Bio-cellulose dressings
    Suprasorb X
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Biocellulose gel sheet dressing
    Type of wound product is suitable for
    Light to moderately, non infected exuding wounds
    Duration dressing remains on wound before changing
    1-7 days
    Frequency of dressing change
    1-7 days, dependent on exudate levels
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Known sensitivity to any components of the dressing
    Rationale for inclusion in formulary
    Light to moderate exudate.
     
       
    A5.02.04  Hydrocolloid dressings to top
    A5.02.04  Without adhesive border
    Duoderm range of dressings
    View adult BNF View SPC online View childrens BNF
    First Choice
    Green
    The adhesive layer forms a cohesive gel when in contact with wound exudate
    Available as Extra thin or Signal (Bordered)

    Type of wound product is suitable for
    Dry to lightly exuding wounds
    Non infected
    Acute or Chronic wounds

    Duration dressing remains on wound before changing
    Up to 7 days maximum

    Frequency of dressing change
    3-7 days

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Not suitable for infected wounds, full thickness burns or wounds with exposed bone, muscle or tendon or wounds that are likely to macerate, particularly on plantar surface of foot
    Not for diabetic foot ulcers
    Not for ischaemic wounds
    Known product or component sensitivity

    Rationale for inclusion in formulary
    Conformable, waterproof, aids autolysis. Protect surrounding skin , reduced risk of
    blistering. Cost effective
     
    BeneHold TASA
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green

    Approved April 2019

    Hydrocolloid Range with film border

    Type of wound product is suitable for
    Lightly to moderately exuding wounds

    Duration dressing remains on wound before changing
    Up to 7 days

    Frequency of dressing change
    Only when necessary - up to 7 days

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Do not use on third-degree burns. Should not be used on individuals who are sensitive to or have had an allergic reaction to the dressing or its components.

    Rationale for inclusion in formulary
    Reduced dressing changes. More cost effective. Reduce use of more expensive foam dressings.

     
       
    Granuflex
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Type of wound product is suitable for
    Hyperkeratosis, granulating wounds, forms cohesive gel on contact with exudate

    Duration dressing remains on wound before changing
    Up to 7 days

    Frequency of dressing change
    3-7 days

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Known sensitivity to ingredients - contains pectin and gelatine
    Not for diabetic foot ulcers or ischaemic wounds
    Not for infected wounds

    Rationale for inclusion in formulary
    Comformable waterproof dressing, aids rehydration.
    Reduces and softens hyperkeratosis
     
       
    A5.02.04  With adhesive border
    A5.02.04  Hydrocolloid-fibrous dressings
    Aquacel range
    (excluding Aquacel Ag)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Type of wound product is suitable for
    Moderate to heavy exudate, sloughy, necrotic or granulating wounds. Available in rope
    for cavities

    Duration dressing remains on wound before changing
    Maximum 7 days

    Frequency of dressing change
    1-7 days depends on clinical need

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Not suitable for dry wounds. Non dissolvable. Known product or component sensitivity
    Do not cut

    Rationale for inclusion in formulary
    Aids debridement of slough or necrotic tissue
    Remains intact so easily removed in one piece
    Absorbs exudate which aids most wound healing facilitating atraumatic dressing change,
    Cost effective
     
       
    UrgoClean
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green

    Type of wound product is suitable for

    All non-infected sloughy wounds. Diabetic foot ulcers

    Duration dressing remains on wound before changing

    1-3 days during the wound desloughing phase, then as often as required (up to 7 days) depending on the level of exudate and the clinical condition of the wound.

    Frequency of dressing change

    1-7 days dependent on clinical assessment.  

    Caution/Contraindications (when not to use the dressing, patient groups to avoid etc.)

    Known sensitivity to any component of the dressing.

    Rationale for inclusion in formulary

    No other comparable dressing available.

     
       
    A5.02.04  Polyurethane matrix dressing
    A5.02.05  Foam dressings to top
    A5.02.05  For lightly exuding wounds
    A5.02.05  For lightly to moderately exuding wounds
    Allevyn range
    (excluding Allevyn Ag)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Available in adhesive, non adhesive and gentle
    Type of wound product is suitable for
    Wound management by secondary intention on acute, chronic, full thickness or partial thickness or shallow granulating wounds including pressure ulcers, leg ulcers, diabetic foot ulcers, malignant wounds surgical wounds, malignant wounds donor sites and fungating ulcers
    Can be used as a primary or secondary dressing
    Duration dressing remains on wound before changing
    Can stay in place up to 3-7 days

    Frequency of dressing change
    Dependent on exudate levels
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    In common with all adhesive products, some cases of irritation and/or maceration of the skin may occur.
    It should be noted that inappropriate use or too frequent dressing changes, particularly in patients with fragile skin, can result in skin stripping. If this occurs change to the Allevyn gentle border range.
    If redness or sensitisation occur, discontinue use
    Caution under compression when exudate levels are moderate to high.
    Rationale for inclusion in formulary
    Can be used for low to moderate exudate levels
    Different sizes and shapes available
    Cost effective
     
       
    A5.02.05  For moderately to heavily exuding wounds
    ActivHeal Foam
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Two layer dressing consisting of a polyurethane bacterial barrier membrane with a centrally located hydrophilic pad +/- acrylic adhesive border.

    Type of wound product is suitable for
    Moderately exuding wounds with signs of granulation, epithelialisation or slough. Can be used as primary or secondary

    Duration dressing remains on wound before changing
    1-7 days

    Frequency of dressing change
    Up to 7 days dependent on exudate levels

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Full thickness burns
    Surgical implantations

    Rationale for inclusion in formulary
    Cost effective
    Simple to use on the foot and digits
    Can be cut to shape 
       
    ActivHeal Foam (Tracheostomy)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Tracheostomy foam dressing

    Type of wound product is suitable for
    ActivHeal Foam Tracheostomy dressing has a fenestration, which allows the dressing to fit neatly around a tracheostomy tube. The dressing can also be used around intubation and cannula insertion procedures, external bone fixators and appropriately-sized wound drainage tubes.

    Duration dressing remains on wound before changing
    Dependant on clinical need and soiling

    Frequency of dressing change
    Up to 7 days, dependant on clinical need and soiling

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Do not use if reaction to any of its components

    Rationale for inclusion in formulary
    Specific dressing shaped and able to cut for tracheostomies.
    Cost effective
     
       
    Allevyn Cavity
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Type of wound product is suitable for
    Wound management by secondary intention on acute, chronic, full thickness or partial
    thickness or shallow granulating wounds including pressure ulcers, leg ulcers, diabetic foot ulcers, malignant wounds surgical wounds, malignant wounds donor sites and fungating ulcers
    Can be used as a primary or secondary dressing

    Duration dressing remains on wound before changing
    Can stay in place up to 3-7 days

    Frequency of dressing change
    Dependent on exudate levels

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    In common with all adhesive products, some cases of irritation and/or maceration of the skin may occur.
    It should be noted that inappropriate use or too frequent dressing changes, particularly in patients with fragile skin, can result in skin stripping. If this occurs change to the Allevyn gentle border range.
    If redness or sensitisation occur, discontinue use
    Caution under compression when exudate levels are moderate to high.

    Rationale for inclusion in formulary
    Can be used for low to moderate exudate levels
    Different sizes and shapes available
    Cost effective
     
       
    Allevyn Non-Adhesive
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Type of wound product is suitable for
    Wound management by secondary intention on acute, chronic, full thickness or partial
    thickness or shallow granulating wounds including pressure ulcers, leg ulcers, diabetic foot ulcers, malignant wounds surgical wounds, malignant wounds donor sites and fungating ulcers
    Can be used as a primary or secondary dressing

    Duration dressing remains on wound before changing
    Can stay in place up to 3-7 days

    Frequency of dressing change
    Dependent on exudate levels

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    In common with all adhesive products, some cases of irritation and/or maceration of the skin may occur.
    It should be noted that inappropriate use or too frequent dressing changes, particularly in patients with fragile skin, can result in skin stripping. If this occurs change to the Allevyn gentle border range.
    If redness or sensitisation occur, discontinue use
    Caution under compression when exudate levels are moderate to high.

    Rationale for inclusion in formulary
    Can be used for low to moderate exudate levels
    Different sizes and shapes available
    Cost effective
     
       
    Biatain dressings
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Polyurethane foam dressing with bevelled edges

    Type of wound product is suitable for
    Moderately exuding wounds with signs of granulation, epithelialisation or slough.
    Can be used as primary or secondary

    Duration dressing remains on wound before changing
    1-7 days

    Frequency of dressing change
    Up to 7 days dependent on exudate levels

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Do not use with oxidising solutions such as hydrogen peroxide
    Full thickness burns
    Surgical implantations

    Rationale for inclusion in formulary
    Simple to use on the foot and digits Can be cut to shape
     
       
    PolyMem
    (excluding PolyMem Ag)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Foam dressing that contains a cleansing agent and glycerol

    Type of wound product is suitable for
    Low to moderately exuding wound including skin tears, and other traumatic wounds,
    superficial and partial thickness wounds, burns, donor and graft sites and radiotherapy induces reactions

    Duration dressing remains on wound before changing
    2-7 days

    Frequency of dressing change
    Up to 7 days dependent on exudate levels

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Sensitivity to ingredients contained within the dressing
    Not for full thickness burns Not for ischaemic wounds Not for diabetic foot wounds
    Not in conjunction with solutions containing hypochlorite

    Rationale for inclusion in formulary
    Suitable for fragile and sensitive skin, Soft and comformable,
    Easy to redress awkward areas
    Wide range of sizes including digit shaped dressings
     
       
    Tegaderm Foam Adhesive
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Type of wound product is suitable for
    Wound management by secondary intention on acute, chronic, full thickness or partial thickness or shallow granulating wounds including pressure ulcers, leg ulcers, diabetic foot ulcers, malignant wounds, surgical wounds, donor sites and fungating ulcers
    Can be used as a primary or secondary dressing
    Film border increases adherence

    Duration dressing remains on wound before changing
    Can stay in place up to 3-7 days

    Frequency of dressing change
    Dependent on exudate levels

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Care with fragile skin

    Rationale for inclusion in formulary
    Can be used for low to moderate exudate levels
    Different sizes and shapes available
    Conformability around difficult areas such as heels and elbows
    Can be used on sacral and buttock wounds where incontinence is an issue due to film backing and border.
     
       
    A5.02.06  Alginate dressings
    Sorbsan range
    (excluding Sorbsan Ag)
    View adult BNF View SPC online View childrens BNF
    First Choice
    Green
    Calcium alginate dressing

    Type of wound product is suitable for
    Use in moderate to highly exuding wounds with a sloughy or granulating wound bed. Also helps with haemostasis in wounds with minor bleeding or where blood is present in the exudate.
    Available in flat and rope dressing
    Primary dressing only. Secondary dressing will be required.

    Duration dressing remains on wound before changing
    Can be left in place for approximately 4 days

    Frequency of dressing change
    1-4 days dependent on exudate levels

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Do not use in individuals with a known sensitivity to any of the components of the dressing
    Do no use on dry or lightly exuding wounds as adherence is an issue
    Extreme caution if used for tumours with friable tissue

    Rationale for inclusion in formulary
    Sorbsan can facilitate debridement, absorb exudate and is a haemostat
    Cost effective
    Biodegradable
     
    Urgosorb
    (excluding Urgosorb Ag)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Type of wound product is suitable for
    Management of moderate to heavily exuding wounds. Absorbs and gels on contact with
    wound exudate which facilitates debridement of devitalised tissue. Dressing has haemostatic properties

    Duration dressing remains on wound before changing
    1-7 days dependent on exudate levels

    Frequency of dressing change
    1-7 days dependent on exudate levels

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Known sensitivity to any of the dressing components Contraindicated in 3rd degree burns, dry necrotic eschar
    Low exudate or dry wounds

    Rationale for inclusion in formulary
    Can be used for moderate to heavily exuding wounds
    Can be used for debriding sloughy and wet necrotic wounds
    Haemostatic
     
       
    A5.02.07  Capillary-action dressings to top
    A5.02.08  Odour absorbent dressings

    View adult BNF View SPC online View childrens BNF
    First Choice
    Green
    Consider first line dressings appropriate to wound bed type and exudate level 
    CarboFLEX
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Odour absorbent wound contact dressings containing activated charcoal

    Type of wound product is suitable for
    For the management of moderate to heavily exuding malodorous wounds including
    fungating

    Duration dressing remains on wound before changing
    Up to 7 days

    Frequency of dressing change
    As exudate level determines

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Known sensitivity to the dressing or its components
    As soon as CarboFLEX becomes contaminated with exudate, odour control diminishes
    The underlying cause of wound odour should be identified prior to commencement of product

    Rationale for inclusion in formulary
    CarboFLEX is a layered dressing to provide higher levels of fluid handling
    On shallow or cavity wounds with moderate to heavy levels of exudate
     
       
    Clinisorb
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Odour absorbent charcoal dressing

    Type of wound product is suitable for
    Malodourous wounds such as fungating wounds

    Duration dressing remains on wound before changing
    Up to 7 days

    Frequency of dressing change
    1-7 days dependent on exudate levels

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Not indicated as a primary dressing in dry wounds
    Store at room temperature
    Exudate levels will reduce the effectiveness of the charcoal

    Rationale for inclusion in formulary
    Clinisorb is an activated charcoal dressing which adsorb toxins removing malodour from the wound
    Can be cut to size
    Cost effective
     
       
    A5.03  Antimicrobial dressings
     note 

    Avoid routine or prophylactic use of antimicrobials on non-infected wounds.
    Also see alternative indications for short-term use below.

    A5.03.01  Honey
    A5.03.01  Sheet dressing
    Actilite (Honey Dressing)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Non-adherent viscose net dressing 99% Manuka honey and 1% Manuka oil.

    Type of wound product is suitable for
    A primary dressing for low to moderate shallow exuding wound with light slough. Granulating or
    epithelialising wounds with clinical signs of infection. Requires a secondary dressing.

    Max Duration dressing remains on wound before changing
    3-7 Days

    Frequency of dressing change
    3 to 7 days depending on exudate

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Known allergy to Bee Venom and Honey products
    Blood sugars should be monitored in patients with diabetes
    Stinging sensation may be experienced. If unacceptable for patient then discontinue.

    Rationale for inclusion in formulary
    For antimicrobial and de-sloughing properties
    Ease of application
    Can be cut to size
    Easy removal in one piece
    Availability of different sizes
    Not found to be harmful to peri-wound skin
    Malodour
    Cost effective 
       
    Activon Tulle (Honey Dressing)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Knitted viscose mesh impregnated with 100% Manuka Honey.

    Type of wound product is suitable for
    Creates a moist healing environment effectively eliminates odour. Provides anti-microbial action.
    Debrides and de-sloughs shallow wounds where the exudate level has started to decrease. Requires secondary dressing

    Max Duration dressing remains on wound before changing
    Up to 4 days

    Frequency of dressing change
    Daily in acute infection
    Up to 4 days for chronic infection depending on exudate

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Wounds with active blood loss
    Known allergies to bee Venom and Honey products
    Blood sugars should be monitored in diabetic patients
    Stinging sensation may be experienced – discontinue if not tolerant.

    Rationale for inclusion in formulary
    Anti-microbial and de-sloughing properties for wounds with reduced levels of exudate.
    Control of odours
    Ease of application and removal in one piece
    Can be cut to size
    Available to various size
    Cost effective 
       
    Algivon (Honey Dressing)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Alginate dressing impregnated with 100% Manuka Honey.

    Type of wound product is suitable for
    Primary dressing for infected, shallow cavity wounds, particularly if necrotic or malodorous with
    moderate exudate. Requires secondary dressing.

    Max Duration dressing remains on wound before changing
    Up to 4 days for chronic infection

    Frequency of dressing change
    Daily for acute infection
    Up to 4 days for chronic infection/depending upon exudate

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Wounds with active blood loss
    Known allergy to be venom and honey products
    Blood sugars should be monitored in diabetic patients
    Stinging sensation may be experienced – discontinue if not tolerated

    Rationale for inclusion in formulary
    Antimicrobial and de sloughing properties
    Absorbent
    Malodour
    Ease of application and removal in one piece
    Can be cut to size
    Available in various sizes
    Can be shaped to wound size and depth
    Cost effective 
       
    L-Mesitran ®
    (Hydro/ Hydro border)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Red
    A hydro active gel dressing containing medical grade honey available without or with an adhesive film border. L- Mesitran has anti bacterial properties and can debride and reduce malodour.

    Type of wound product is suitable for
    Burns, chronic wounds, necrotic/sloughy wounds, surgical wounds, diabetic ulcers with caution, donor sites, fungating wounds.

    Max Duration dressing remains on wound before changing
    3-7 days

    Frequency of dressing change
    3- 7 days, dependent on exudate level

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Known sensitivity to dressing and any of its components use with caution in patients with bee venom allergy
    Not suitable for full thickness burns/deep narrow cavities
    Caution must be exercised when applying to diabetic patients. Blood glucose levels must be monitored.

    Rationale for inclusion in formulary
    Desloughing, Antimicrobial, Deodorising 
       
    A5.03.01  Honey-based topical application to top
    Activon ®Tube
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    100% medical grade Manuka Honey.

    Type of wound product is suitable for
    Use as topical treatment for infected sloughy shallow or cavity wounds. Primary or addition to other Activon products. Requires secondary dressing.

    Max Duration dressing remains on wound before changing
    Up to 4 days

    Frequency of dressing change
    Daily in acute infection
    Up to 4 days in chronic infection dependant on exudate

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Wounds with active blood loss
    Known allergies to bee Venom and Honey products
    Blood sugars should be monitored in diabetic patients
    Stinging sensation may be experienced – discontinue if not tolerant.

    Rationale for inclusion in formulary
    Anti-microbial and de-sloughing properties
    Control of odours
    Benefit of adding to other action products and increasing honey
    Suitable for use in cavities
    Cost effective 
       
    A5.03.02  Iodine
    Inadine ®
    View adult BNF View SPC online View childrens BNF
    First Choice
    Green
    Non-adherent dressing impregnated with povidone iodine (10%)

    Type of wound product is suitable for
    Mild local infection where there is low exudate levels, ischaemic wounds, dry, gangrenous digits with the aim to desiccate and auto-amputate.
    Dry-manage fixator sites
    Minor burns or skin trauma with local infection

    Duration dressing remains on wound before changing
    1-3 days depending on uptake of iodine from dressing

    Frequency of dressing change
    1-3 days depending on uptake of iodine from dressing
    Look at colour change of dressing (orange initially to white when all used)

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Iodine allergy or sensitivity
    Thyroid disorders
    Renal impairment
    Not suitable for children, pregnant or lactating women

    Rationale for inclusion in formulary
    Topical antimicrobial
    Non-adherent/pain free use
    No damage to granular or epithelial cells
    Easy application and removal
    Drying properties
    Efficacy against bacteria, fungi and viruses
    Cost effective. 
    Iodoflex®
    View adult BNF View SPC online View childrens BNF
    First Choice
    Green
    Cadexomer dressing containing iodine

    Type of wound product is suitable for
    Iodine paste in mesh form for chronic infected, sloughy wounds with moderate exudate eg pressure ulcers, leg ulcers, diabetic foot ulcers
    Can be used under compression bandaging

    MAX Duration dressing remains on wound before changing
    Up to 3 days

    Frequency of dressing change
    Daily for acute infection
    Up to 3 days for chronic wounds and infection, depending on exudate levels

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Allergy or sensitivity to iodine
    Precaution with large wounds due to absorption. Do not use more than 50g in a single application and no more than 150g in 7 days
    Dry necrotic wounds
    Thyroid disorders
    Renal impairment
    Not suitable for children, pregnant or lactating mothers
    Concurrent Lithium therapy

    Rationale for inclusion in formulary
    Anti microbial, broad spectrum, long acting/high absorption capacity
    Removes slough and debris to clean the wound bed
    Can be moulded to shape of the wound
    Alternative to honey products if allergy to bees 
    Iodosorb®
    View adult BNF View SPC online View childrens BNF
    First Choice
    Green
    Cadexomer powder or ointment with iodine

    Type of wound product is suitable for
    Chronic exuding sloughy wounds eg leg ulcers, pressure ulcers, diabetic foot ulcers. Can be used under compression bandaging

    Duration dressing remains on wound before changing
    Up to 3 days

    Frequency of dressing change
    Daily for acute infection
    Up to 3 days for chronic infection

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Allergy to iodine products
    Dry necrotic tissue
    Not suitable for Children, pregnant or lactating mothers
    Thyroid disorders
    Renal impairment
    Needs at least twice weekly dressings for iodine to be effective

    Rationale for inclusion in formulary
    Antimicrobial, broad spectrum, long acting
    De-slough and cleans wound debris
    Non-adherant. Reduces trauma to wound and pain on dressing changes
    Easy application. Can fill cavities or awkward shaped wounds
    Alternative to honey based products if allergy to bees 
    A5.03.03  Silver
    A5.03.03  Low adherence dressings
    Atrauman Ag®
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Non adherent Primary Dressing containing metallic silver

    Type of wound product is suitable for
    For clinically infected shallow, granulating wounds with low exudate. To be used as a primary dressing with a secondary for absorption.

    Duration dressing remains on wound before changing
    Up to 7 days

    Frequency of dressing change
    1-7 days, depending on levels of exudate

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Known product or component sensitivity
    Must be removed prior to x-ray, ultrasound, diathermy and MRI

    Rationale for inclusion in formulary
    Used to reduce adherence to wound bed with clinical signs of infection
    Most cost effective non adherent dressing containing silver.
    Dressing impregnated with neutral triglycerides to prevent penetration of granulation tissue.
    Petroleum free.
    Specialist Recommendation 
       
    A5.03.03  With charcoal
    A5.03.03  Soft polymer dressings to top
    A5.03.03  Hydrocolloid dressings
    Aquacel® Ag + Extra range
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Hydrofibre with silver

    Type of wound product is suitable for
    Management of clinically infected, sloughy, necrotic or granulating wounds with moderate to heavy exudate.
    Moderate to highly exuding wounds.
    Aquacel Ag Plus Extra can be used to break down biofilms
    Requires a secondary dressing

    Duration dressing remains on wound before changing
    Dependent upon exudate 1 - 7 days

    Frequency of dressing change
    Dependent upon level of exudate and clinical presentation

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Should not be used on individuals who are sensitive to or have had an allergic reaction to the dressing or its components.
    Not suitable for dry wounds.
    No haemostatic properties.

    Rationale for inclusion in formulary
    Specialist antimicrobial product
    Moderate to high exudate levels
    Can be used to break down biofilms
    Remains intact on wound bed and easily removable in one piece (non dispersible) 
       
    A5.03.03  Foam dressings
    Allevyn Ag®
    View adult BNF View SPC online View childrens BNF
    Restricted Drug Restricted
    Red
    A non adherent foam dressing impregnated with silver sulphadiazine that can be cut to suit the patient
    Type of wound product is suitable for
    For use around infected pin sites
    Duration dressing remains on wound before changing
    Daily or as directed
    Frequency of dressing change
    Daily
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Patients who have a known sensitivity to Silver Sulphadiazine or Sulphonamides
    Females who are at or near full term pregnancy or lactating
    Not for use on neonates or new born infants during the first month of life
    Rationale for inclusion in formulary
    Used around infected pin sites in patients with external metalwork to help reduce bacterial load
    HOSPITAL USE ONLY 
       
    A5.03.03  Alginate dressings
    Urgosorb Silver® range
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Alginate and hydrocolloid dressings containing silver
    Type of wound product is suitable for
    Management of moderate to heavily exuding wounds that are clinically infected. Absorbs and gels on contact with wound exudate which facilitates debridement of devitalised tissue.
    Dressing has haemostatic properties
    Duration dressing remains on wound before changing
    1-3 days dependent on exudate levels
    Frequency of dressing change
    1-3 days dependent on exudate levels
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Known sensitivity to any of the dressing components
    Contraindicated in 3rd degree burns, dry necrotic eschar
    Low exudate or dry wounds
    Removal on those undergoing MRI scans
    Avoid contact with electrodes or conductive gels during electronic measurement procedures
    Rationale for inclusion in formulary
    Can be used for moderate to heavily exuding clinically infected wounds
    Can be used for debriding sloughy and wet necrotic wounds
    Haemostatic
    Specialist Recommendation 
       
    A5.03.04  Other antimicrobials
    Flaminal ® Forte Gel
    View adult BNF View SPC online View childrens BNF
    First Choice
    Green
    Alginate gel. Moderate to heavily exuding wounds. Contains antimicrobial enzymes.

    Type of wound product is suitable for
    Colonised wound bed. More suited to sloughy wounds. Can be used on all wound types
    Useful for cavity wounds and sinus’s
    Requires a secondary dressing

    Duration dressing remains on wound before changing
    1-7 days

    Frequency of dressing change
    1-7 days dependent on exudate levels

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Sensitivity to alginate dressings or polyethylene glycol
    Full thickness burns

    Rationale for inclusion in formulary
    1st line antimicrobial in paediatrics
    Consider as first line product if signs of colonisation or clinical infection
    Does not cause cellular damage 
    Kytocel®
    View adult BNF View SPC online View childrens BNF
    First Choice
    Green
    Absorbent gelling fibre wound dressing

    Type of wound product is suitable for
    Moderate to heavily exuding chronic and acute wounds that are sloughy and clinically infected.
    Haemostatic properties for minor bleeds in superficial wounds
    Autolytic debridement properties

    Duration dressing remains on wound before changing
    1-3 days

    Frequency of dressing change
    1-3 days, dependent on exudate levels

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Allergy to Shellfish (Chitin)
    Full thickness burns
    Heavily bleeding wounds
    Dry wounds

    Rationale for inclusion in formulary
    Cost effective
    Alternative to available antimicrobials
    Can be used on heavily exuding wounds 
    Flaminal ®Hydro Gel
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Alginate gel. Low to moderate exuding wounds. Contains antimicrobial enzymes

    Type of wound product is suitable for
    Colonised wound bed. More suited to sloughy wounds. Can be used on all wound types
    Useful for cavity wounds and sinus’s
    Requires a secondary dressing

    Duration dressing remains on wound before changing
    1-7 days

    Frequency of dressing change
    1-7 days dependent on exudate levels

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Sensitivity to alginate dressings or polyethylene glycol
    Full thickness burns

    Rationale for inclusion in formulary
    1st line antimicrobial in paediatrics
    Consider as first line product if signs of colonisation or clinical infection
    Does not cause cellular damage 
       
    Cutimed ®Sorbact
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    DACC coated dressings providing antimicrobial properties, available in a pad, gel, gel sheet, ribbon, round swab and rectangular swab

    Type of wound product is suitable for
    Colonised or clinically infected moist wound, suitable for any wound type

    Duration dressing remains on wound before changing
    1-3 days

    Frequency of dressing change
    1-3 days dependent on exudate levels

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Do not use in combination with oils and creams
    Known hypersensitivity to ingredients
    Not for dry wound
    Not for heavily exuding wounds

    Rationale for inclusion in formulary
    Alternative to available antimicrobials 
       
    Kendall AMD®
    View adult BNF View SPC online View childrens BNF
    Formulary
    Red
    Absorbent, non adherent foam disc impregnated with PHMB. Double sided with a centre hole and radial slit
    Type of wound product is suitable for
    For use on pin sites, drains and tubes.
    Duration dressing remains on wound before changing
    1-7 days
    Frequency of dressing change
    1-7 days dependent on exudate levels
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Not intended as a primary treatment for infection
    Do not use as a primary treatment for full thickness burns
    Not for patients sensitive to PHMB
    Rationale for inclusion in formulary
    Provides local exudate management and antimicrobial properties
    Absorbent
    Non adherent and semi occlusive
    For specialist use only 
       
    Prontosan Wound Gel 30ml
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    A gel containing betaine, a surfactant to remove biofilm and debris and PHMB to help control bacterial bioburden.

    Type of wound product is suitable for
    Cleansing, decontamination and moisturising of acute and chronic wounds including 1st and 2nd degree burns.

    Duration dressing remains on wound before changing
    Apply at each dressing change

    Frequency of dressing change
    As determined by the wound and exudate levels

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    None

    Rationale for inclusion in formulary
    Gel to cleanse and decontaminate wounds
    Antimicrobial
    Breaks down biofilms in chronic wounds 
       
    Prontosan Wound Irrigation Solution
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Wound irrigation solution containing betaine a surfactant to remove biofilm and debris and PHMB to help control bacterial bioburden.

    Type of wound product is suitable for
    Cleansing, decontamination and moisturising of acute and chronic wounds including 1st and 2nd degree burns.

    Duration dressing remains on wound before changing
    Apply at each dressing change

    Frequency of dressing change
    As determined by the wound and exudate levels

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    None

    Rationale for inclusion in formulary
    Solution to cleanse and decontaminate wounds
    Antimicrobial
    Breaks down biofilms in chronic wounds
    Can be used as an irrigation fluid with VAC Veraflow 
       
    Suprasorb X + PHMB
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Biocellulose gel sheet dressing with PHMB antimicrobial properties

    Type of wound product is suitable for
    Light to moderately, critically colonised or infected exuding wounds
    Can be used on all wound types at all stages of wound healing
    Can be cut or folded to wound shape size

    Duration dressing remains on wound before changing
    1-3 days

    Frequency of dressing change
    1-3 days, dependent on exudate levels

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Known sensitivity to PHMB or any components of the dressing
    Heavily exuding wounds

    Rationale for inclusion in formulary
    Light to moderate exudate in clinically infected wounds.
    Suitable for all wounds at all stages of wound healing
    Doesn’t affect healthy cells, suitable for long term use when necessary
    Specialist recommendation 
       
    A5.04  Specialised dressings to top
    A5.04.01  Protease-modulating matrix dressings
    UrgoSTART® range
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    A non adherent foam and contact layer impregnated with TLC-NOSF healing matrix to promote healing and prevent the detrimental effects of MMPs.
    Type of wound product is suitable for
    Low to moderately exuding chronic wounds
    Duration dressing remains on wound before changing
    Up to 7 days
    Frequency of dressing change
    1-7 days dependent on exudate levels.
    Treatment must be a minimum duration of 4-5 weeks.
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Do not use on infected or critically colonised wounds
    Known sensitivities to dressing components
    Rationale for inclusion in formulary
    Various sizes available including a shaped heel dressing in the foam range
    Pain free dressing changes
    Promotes wound healing
    Interacts with the wound bed to prevent the detrimental effects of MMPs on wound healing 
       
    A5.04.02  Silicone keloid dressings
    A5.04.02  Silicone sheets
    Cica-Care
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Silicone sheet for scar treatment

    Type of wound product is suitable for
    Not for use on open wounds- to be applied on healed scar only.
    This is not a dressing but a scar treatment

    Duration dressing remains on wound before changing
    23 hours

    Frequency of dressing change
    Daily

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Do not use on open or infected wounds. Do not use on skin affected by acne. Discontinue use if a rash or itching occur.

    Rationale for inclusion in formulary
    Scar therapy
    Silicone sheets have been shown to soften, flatten scarring aiding movement, nerve sensations and function. Self adherent, Re-usable
     
       
    Mepiform
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Silicone sheet for scar treatment

    Type of wound product is suitable for
    Not for use on open wounds- to be applied on healed scar only.
    This is not a dressing but a scar treatment

    Duration dressing remains on wound before changing
    23 hours

    Frequency of dressing change
    Daily

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Do not use on open or infected wounds. Do not use on skin affected by acne. Discontinue use if a rash or itching occur.

    Rationale for inclusion in formulary
    Scar therapy
    Silicone sheets have been shown to soften, flatten scarring aiding movement, nerve sensations and function.
    Cost effective. 
       
    A5.04.02  Silicone gel
    A5.05  Adjunct dressings and appliances to top
    A5.05.01  Gauze and tissue
    A5.05.01  Surgical absorbents
    A5.05.01  Cotton
    Sterile Gauze swabs 7.5cmx7.5cm ONLY
    (non woven)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    7.5cm x 7.5cm only
    Type of wound product is suitable for
    Cleansing wounds via aseptic technique
    Duration dressing remains on wound before changing
    N/A
    Frequency of dressing change
    N/A
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Not to be applied to a wound as a dressing
    Necessity for wound cleansing
    Cost effective
    Included in Sterile wound packs or used to supplement sterile packs
     
       
    Gamgee
    (UHB burns unit ONLY)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Red
    Sterile or non sterile highly absorbent cotton wool enclosed in an absorbent cotton cover
    Type of wound product is suitable for
    Full thickness burns
    Can be cut to required size
    Secondary dressing
    Duration dressing remains on wound before changing
    Dependent on exudate levels
    Frequency of dressing change
    Dependent on exudate levels
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Not to be used as a primary dressing
    Only to be used in UHB burns unit
    Rationale for inclusion in formulary
    UHB burns unit only
     
       
    A5.05.01  Lint
    A5.05.01  Pads to top
    Xupad range
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Latex free absorbent dressing pad
    Type of wound product is suitable for
    Low exuding closed surgical wounds only
    Duration dressing remains on wound before changing
    1 – 7 days depending on exudate
    Frequency of dressing change
    1 – 7 days depending on exudate
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Not for moderate or highly exuding wounds. Always consider an interactive dressing. Not suitable for any wound type except for closed surgical wounds
    Rationale for inclusion in formulary
    Cost effective
    Various sizes available 
       
    A5.05.02  Wound drainage pouches

    View adult BNF View SPC online View childrens BNF
    First Choice
    Green
    Consider standard interactive dressings first 
    Oakmed Option Wound Manager
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Wound drainage system consisting of a hydrocolloid adhesive wafer and a drainable drainage bag

    Type of wound product is suitable for
    Complex abdominal wounds, moderate to large fistula’s, orthopaedic wounds or
    fungating wounds with high levels of exudate, that are unmanaged with conventional dressings.

    Max Duration dressing remains on wound before changing
    Empty drainage bag as required. If no port for drainage, change as required.

    Frequency of dressing change
    As long as adhesive remains intact whilst being mindful of skin integrity

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Known product component sensitivity to hydrocolloid (Gelatine and Pectin)
    Low to moderate exuding wounds
    Do not use if a conventional dressing can manage the exudate levels

    Rationale for inclusion in formulary
    Various size selection with drainage ports and windows
    For highly exuding wounds that conventional dressings cannot manage the exudate levels


     
       
    A5.05.03  Physical debridement pads
    UCS® Debridement
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green

    Single use pre- moistened cloth for wound debridement.  Can be used to remove hyperkeratosis.


    Type of wound product is suitable for

    All acute and chronic wounds including pressure ulcers, leg ulcers, diabetic foot ulcers.

    Hyperkeratosis


    Duration dressing remains on wound before changing
    Not applicable


    Frequency of dressing change
    At each dressing change or as required


    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Heavy slough and necrotic tissue may require autolytic debridement to soften prior to use
    Thick hyperkeratosis may take more than one treatment


    Rationale for inclusion in formulary
    Lifts wound debris, superficial slough and exudate, without inhibiting granulation tissue formation
    Compatible with subsequent use of any type of dressing.
    Lifts hyperkeratosis and dry flaking skin to peri-wound
    Convenient, pre- moistened,  easy to use, disposable single use cloth

     
       
    Debrisoft®
    View adult BNF View SPC online View childrens BNF
    Formulary
    Red
    £££
    Debridement pad to cleanse and debride wounds.
    Type of wound product is suitable for
    Acute or chronic wounds with surface debris eg pressure ulcers, leg ulcers, diabetic foot ulcers
    Hyperkeratosis
    Duration dressing remains on wound before changing
    Not applicable
    Frequency of dressing change
    At each dressing change or as required
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Known sensitivity to polyester
    Heavy slough and necrotic tissue may require autolytic debridement to soften prior to
    use
    Thick hyperkeratosis may take more than one treatment
    Must be wet with clean warm water prior to use
    Do not get an emollient on the pad as this blocks the monofilaments
    Rationale for inclusion in formulary
    Lifts debris, superficial slough and exudate without damaging new granulation or
    epithelial cells
    Removes biofilms
    Lifts hyperkeratosis and dry flaking skin peri-wound
    Recommended by NICE
    Treatment well tolerated
    Convenient, easy to use, disposable single use pad
     
       
    A5.06  Complex adjunct therapies
    A5.06.01  Topical negative pressure therapy

    View adult BNF View SPC online View childrens BNF
    First Choice
    Green
    Consider standard interactive dressings first. Dressings advised by TVN
    Topical Negative Pressure Therapy
    (Dependent on Trust contract)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    The use of sub atmospheric pressure to promote or assist wound healing or to remove fluids from a site. Required components: Pump, Dressings foam or gauze, tubing and canister.

    Type of wound product is suitable for
    Acute, chronic and traumatic wounds. Can be used as a adjunct to surgery and for
    salvage procedures such as wound dehiscence. Benefits are that it removes excess fluid that may contain bacterial pathogens, reduces soft tissue oedema, promotes granulation and provides a moist wound healing environment.
    Consider standard interactive dressings first.
    Duration dressing remains on wound before changing
    Every three days
    Frequency of dressing change
    Determined by exudate levels. Different canister sizes available
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    It should not be used on: Grossly infected or bleeding wounds
    Malignancy
    Exposed blood vessels
    Organs
    Unexplored fistulae
    Extensive necrotic wounds
    Caution with foam, document the number inserted, ensure all pieces are retrieved.

    Rationale for inclusion in formulary
    It removes excess fluid that may contain bacterial pathogens, reduces soft tissue
    oedema, promotes granulation and provides a moist wound healing environment. Both companies products are included due to different contracting arrangements. Can be used on large open wounds to increase speed of wound healing
     
       
    A5.06.01  Vacuum assisted closure products to top
    A5.06.01  Wound drainage collection devices
    PICO products
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Disposable and portable system designed to kick start wound healing. Required
    components: One PICO device, 2 dressings per kit.
    Type of wound product is suitable for
    Acute, chronic, dehisced, partial thickness burns, flaps, grafts and traumatic wounds.
    Consider standard interactive dressings first.
    Duration dressing remains on wound before changing
    Twice a week dressing change, PICO device weekly change
    Frequency of dressing change
    Determined by exudate levels.
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    It should not be used on:
    Confirmed and untreated osteomyelitis
    Malignancy in wound bed or wound margins
    Exposed blood vessels
    Organs
    Unexplored fistulae Necrotic wounds Anastomotic sites
    Emergency airway aspiration
    Pleural, mediastinal or chest tube drainage and surgical suction
    Rationale for inclusion in formulary
    These devices promote patient mobility at a cost effective price and is available on drug
    tariff which other comparable models are not.
     
       
    Renasys products
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    The use of sub atmospheric pressure to promote or assist wound healing or to remove fluids from a site. Required components: Pump, Dressings foam or gauze, tubing and canister.

    Type of wound product is suitable for
    Acute, chronic and traumatic wounds. Can be used as a adjunct to surgery and for
    salvage procedures such as wound dehiscence. Benefits are that it removes excess fluid that may contain bacterial pathogens, reduces soft tissue oedema, promotes granulation and provides a moist wound healing environment.
    Consider standard interactive dressings first.
    Duration dressing remains on wound before changing
    Every three days
    Frequency of dressing change
    Determined by exudate levels. Different canister sizes available
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    It should not be used on: Grossly infected or bleeding wounds
    Malignancy
    Exposed blood vessels
    Organs
    Unexplored fistulae
    Extensive necrotic wounds
    Caution with foam, document the number inserted, ensure all pieces are retrieved.

    Rationale for inclusion in formulary
    It removes excess fluid that may contain bacterial pathogens, reduces soft tissue
    oedema, promotes granulation and provides a moist wound healing environment. Both companies products are included due to different contracting arrangements. Can be used on large open wounds to increase speed of wound healing
     
       
    V.A.C. products
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    The use of sub atmospheric pressure to promote or assist wound healing or to remove fluids from a site. Required components: Pump, Dressings foam or gauze, tubing and canister.

    Type of wound product is suitable for
    Acute, chronic and traumatic wounds. Can be used as a adjunct to surgery and for
    salvage procedures such as wound dehiscence. Benefits are that it removes excess fluid that may contain bacterial pathogens, reduces soft tissue oedema, promotes granulation and provides a moist wound healing environment.
    Consider standard interactive dressings first.
    Duration dressing remains on wound before changing
    Every three days
    Frequency of dressing change
    Determined by exudate levels. Different canister sizes available
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    It should not be used on: Grossly infected or bleeding wounds
    Malignancy
    Exposed blood vessels
    Organs
    Unexplored fistulae
    Extensive necrotic wounds
    Caution with foam, document the number inserted, ensure all pieces are retrieved.

    Rationale for inclusion in formulary
    It removes excess fluid that may contain bacterial pathogens, reduces soft tissue
    oedema, promotes granulation and provides a moist wound healing environment. Both companies products are included due to different contracting arrangements. Can be used on large open wounds to increase speed of wound healing
     
       
    A5.06.01  Accessories
    A5.07  Wound care accessories
    A5.07.01  Dressing packs
    Polyfield Nitrile Patient Pack  (primary care and BCHC, other Trusts as per contract)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Sterile dressing pack
    Type of wound product is suitable for
    To be used on all wounds requiring aseptic dressing procedures
    Duration dressing remains on wound before changing
    Single use
    Frequency of dressing change
    Determined by wound type
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    None listed
    Rationale for inclusion in formulary
    Available on drug tariff, cost effective and incorporates a measure guide which would
    be an additional cost with other packs
     
       
    A5.07.02  Woven and fabric swabs to top
    gauze swabs, non-woven swabs
    (GENERIC PRESCRIBING)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    7.5cm x 7.5cm only

    Type of wound product is suitable for
    Cleansing wounds via aseptic technique

    Duration dressing remains on wound before changing
    N/A

    Frequency of dressing change
    N/A

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Not to be applied to a wound as a dressing

    Rationale for inclusion in formulary
    Necessity for wound cleansing
    Cost effective
    Included in Sterile wound packs or used to supplement sterile packs
     
       
    A5.07.03  Surgical adhesive tapes
    A5.07.03  Permeable adhesive tapes
    Clinipore
    View adult BNF View SPC online View childrens BNF
    First Choice
    Green
    Permeable non woven, synthetic adhesive tape
    For securing bandages

    Frequency of dressing change
    Determined by wound type and dressing change

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    None listed

    Rationale for inclusion in formulary
    Available on drug tariff, cost effective and evaluated as meeting the requirements of a tape including adherence.
     
    Mefix
    View adult BNF View SPC online View childrens BNF
    Second Choice
    Green
    Permeable, aperture non woven, synthetic adhesive tape
    For securing dressings.

    Frequency of dressing change
    Determined by wound type and dressing change

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    None listed

    Rationale for inclusion in formulary
    Available on drug tariff. Different availability of sizes in comparison to Clinipore for
    difficult to dress areas. Some stretch and flexibility to improve conformity and adhesion. Can be used to secure dressings rather than bandages.
     
       
    A5.07.03  Occlusive adhesive tapes
    A5.07.04  Adhesive dressings
    A5.07.04  Vapour permeable adhesive dressings to top
    A5.07.05  Skin closure dressings
    A5.07.05  Skin closure strips, sterile
    Omnistrip®
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Adhesive wound closure strip
    Type of wound product is suitable for
    For atraumatic closure of minor wounds or surgical incisions
    Require a secondary dressing
    Duration dressing remains on wound before changing
    As necessary, up to 14 days
    Frequency of dressing change
    As necessary
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    None
    Rationale for inclusion in formulary
    Cost effective
    Essential for closure of minor injuries
     
       
    A5.08  Bandages
    A5.08.01  Non-extensible bandages
    A5.08.02  Light-weight conforming bandages to top
    Knit -band®
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Cellulose contour bandage used for retention of non adhesive dressing products

    Type of wound product is suitable for
    Retention bandage

    Duration dressing remains on wound before changing
    Change in line with dressing change

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Take care to apply joint below to joint above. Always use a primary dressing

    Rationale for inclusion in formulary
    Most cost effective choice.
     
       
    A5.08.03  Tubular bandages and garments
    A5.08.03  Elasticated
    Clinifast
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    ££
    Elasticated Sub bandage lining

    Type of wound product is suitable for
    To be used under retention and compression bandages when conformity is required
    Can be used for wet/dry wrapping.

    Duration dressing remains on wound before changing
    As required

    Frequency of dressing change
    As required

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Ensure the correct size for a limb is selected

    Rationale for inclusion in formulary
    Cost effective choice when conformity to a limb is required
     
       
    Cotton Stokinette BP
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Sub bandage lining

    Type of wound product is suitable for
    To be used under retention and compression bandages

    Duration dressing remains on wound before changing
    As required

    Frequency of dressing change
    As required

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Not to be used under Coban compression therapy
    Not to be used under compression hosiery
    Does not conform to a limb shape. If conformity is required, choose Clinifast

    Rationale for inclusion in formulary
    Cost effective choice when conformity to a limb is not required
     
       
    A5.08.03  Non-elasticated
    A5.08.03  Silk Clothing
     note  All Silk garments are non-formulary in view of only poor evidence to support prescribing of silk garments in children and adults with eczema/ atopic dermatitis.  

    Please refer to UKMI Midlands Trent Medicines Information Service Silk Garments for Eczema/Atopic Dermatitis June 2014 http://www.midlandsmedicines.nhs.uk/filestore/SilkGarments.pdf

    Randomised controlled trial of silk therapeutic garments for the management of atopic eczema in children: the CLOTHES trial

    A5.08.04  Support bandages to top
    K- Lite
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Lightweight knitted bandage

    Type of wound product is suitable for
    Designed for use on sprains/strains
    Can be used to prevent oedema, would require a wadding bandage to be applied
    beneath
    It is the second layer of a four layer compression bandage kit
    Where there is open skin, a primary dressing must be used

    Duration dressing remains on wound before changing
    Change in line with primary dressing

    Frequency of dressing change
    1-7 days

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Known allergy to any components
    Not suitable for application of pressure on its own and therefore should be used with other bandage components for the treatment of venous ulcers
    Caution over bony prominences where the bandage can cause pressure

    Rationale for inclusion in formulary
    Cost effective
    Essential for providing support to a limb and as part of a bandage compression therapy kit


     
       
    A5.08.05  Adhesive bandages
    A5.08.06  Cohesive bandages
    A5.08.06  Cohesive extensible bandages
    Ko-Flex®
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    A water resistant vapour permeable cohesive bandage

    Type of wound product is suitable for
    Venous ulceration, oedema, Managing sprains and strains and following orthopaedic
    surgery
    Forms part of the K four bandage system

    Duration dressing remains on wound before changing
    1 to 7 days

    Frequency of dressing change
    Dependant on exudate levels if wound present or oedema management .

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Not recommended on those patients with an ABPI lower than 0.8.
    Contains latex

    Rationale for inclusion in formulary
    Cohesive bandage that can be used alongside other formulary products
    Forms the 4th layer of a four layer compression bandage system
     
       
    A5.08.07  Compression bandages
    A5.08.07  High compression bandage to top
    A5.08.07  Short stretch compression bandage
    Actico®
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Cohesive inelastic high compression bandage. Short stretch bandage

    Type of wound product is suitable for
    Venous leg ulceration
    Lymphoedema
    Management of chronic oedema

    Duration dressing remains on wound before changing
    Daily to 7 days

    Frequency of dressing change
    Dependant on exudate levels if wound present or oedema management.

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Not recommended on those patients with an ABPI lower than 0.8. Caution in diabetic patients
    Caution when cardiac overload or renal failure present or suspected.

    Rationale for inclusion in formulary
    Only cohesive short stretch bandage. Nurses competent in its usage.
     
       
    Comprilan®
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    100 % cotton short stretch compression bandage

    Type of wound product is suitable for
    Venous leg ulceration
    Varicosis
    Management of chronic oedema
    Management of primary and secondary lymphoedema
    Deep venous thrombosis
    Thrombophlebitis

    Duration dressing remains on wound before changing
    1 to 7 days

    Frequency of dressing change
    Dependant on exudate levels if wound present or oedema management.

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Advanced Peripheral arterial occlusive disease
    Decompensated cardiac insufficiency
    Septic phlebitis
    Phlegmasia coerula doleris

    Rationale for inclusion in formulary
    Cotton short stretch bandage. Used by lymphoedema nurse specialists
     
       
    A5.08.07  Sub-compression wadding bandage
    Cellona®
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Sub compression wadding bandage to pad and shape a limb prior to compression therapy

    Type of wound product is suitable for
    Provides padding for larger limbs under compression.

    Duration dressing remains on wound before changing
    Up to 7 days

    Frequency of dressing change
    Daily up to weekly dependant on exudate and oedema management.

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Advised not to apply directly to skin as can cause irritation.

    Rationale for inclusion in formulary
    Cost effective for use in larger quantities when used in lymphoedema management.
     
       
    K Soft®
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    An absorbent non –woven, sub bandage wadding.

    Type of wound product is suitable for
    Provides padding , shaping and protection of the limb prior to the application of
    compression bandage therapy.

    Duration dressing remains on wound before changing
    Up to 7 days

    Frequency of dressing change
    Daily up to weekly dependant on exudate and oedema management.

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Advised not to apply directly to skin as can cause irritation.

    Rationale for inclusion in formulary
    Essential for protecting a limb, padding and shaping
    Forms part of the compression bandage regime. Suitable for use with other formulary products.
     
       
    A5.08.08  Multi-layer compression bandaging
    A5.08.08  Four layer systems
    UrgoK4®
    (Previously known as K-Four)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Multi layer compression system

    Type of wound product is suitable for
    Venous and mixed aetiology leg ulcers and associated conditions

    Duration dressing remains on wound before changing
    1 to 7 days

    Frequency of dressing change
    Daily up to weekly dependant on exudate and oedema management.

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Not recommended for patients with a ABPI of less than 0.8
    Contains latex
    Kit size determined by measuring the ankle after padding with the tape measure pulled
    taught

    Rationale for inclusion in formulary
    Compression system consisting of k-soft , k-lite, k plus 3a or K three c (dependent on
    ankle size) and Ko flex
    Component bandages available in longer lengths for larger limbs
     
       
    A5.08.08  Two layer systems to top
    Coban, Coban Lite®
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Two layer compression system available in full and reduced compression (Coban Lite). Comprises of a latex free foam padding and cohesive bandage.

    Type of wound product is suitable for
    Treatment of venous and mixed aetiology leg ulcers

    Duration dressing remains on wound before changing
    1 to 7 days

    Frequency of dressing change
    Daily up to weekly dependant on exudate and oedema management.

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Arterial disease
    Not to be used with other padding or wadding

    Rationale for inclusion in formulary
    Two layer compression kit, Once applied the two layers form a band to become a single
    layer bandage.
    Bandage technique can be adapted to reduce forefoot oedema (Extra training required)
     
       
    UrgoKTwo®
    (previously know as K-Two)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Two layer bandage system consisting of elastic and inelastic components that provide a sustained graduated compression,.
    Available in K two reduced.

    Type of wound product is suitable for
    Treatment of venous leg ulcers, venous oedema and lymphoedema

    Duration dressing remains on wound before changing
    1 to 7 days

    Frequency of dressing change
    Daily up to weekly dependant on exudate and oedema management.

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Arterial disease
    Diabetic Microangiplathy
    Ischaemic Phlebitis
    Septic thrombosis
    Allergy to any components in particular latex (available in latex free )

    Rationale for inclusion in formulary
    Two layer compression kit.
    Essential for treating venous leg ulceration
    2 layer less bulky for community use and enabling patients to wear foot wear
    Available in latex free option and reduced compression option
     
       
    A5.08.09  Medicated bandages
    Ichthopaste
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Zinc and Ichthammol bandage.

    Type of wound product is suitable for
    Venous leg ulcers Chronic eczema Dermatitis

    Duration dressing remains on wound before changing
    Up to 7 days

    Frequency of dressing change
    Daily up to weekly dependant on skin and wound management.

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Do not use in any cases of sensitivity or allergy to ingredients

    Rationale for inclusion in formulary
    For treatment of dermatitis and chronic eczema when
    venous insufficiency is present.
     
       
    Viscopaste
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Zinc paste bandage.

    Type of wound product is suitable for
    Venous leg ulcers. Where venous insufficiency exists, the paste bandage should be used
    under graduated compression bandaging. Chronic eczema
    Dermatitis

    Duration dressing remains on wound before changing
    Up to 7 days

    Frequency of dressing change
    Daily, up to weekly dependant on skin and wound management.

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Do not use in any cases of sensitivity or allergy to ingredients

    Rationale for inclusion in formulary
    For treatment of dermatitis and chronic eczema when venous insufficiency is present
     
       
    A5.08.09  Medicated stocking
    A5.09  Compression hosiery and garments
    A5.09.01  Graduated compression hosiery
    Graduated compression hosiery
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Based on assessment 
       
    A5.09.01  Accessories to top
    A5.09.01  Suspender
    A5.09.01  Anklets
    A5.09.01  Knee caps
    A5.09.02  Lymphoedema garments
    Lymphoedema garments
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Based on assessment 
       
    A5.10  Larvae to top

    View adult BNF View SPC online View childrens BNF
    Formulary Consider standard dressings first 
       
    LarvE
    (free range or in BioFOAM dressing)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Free range: Biomonde Larvae 100/200 or BioBag
    Biosurgical treatment for the debridement and cleansing of wounds consisting of aseptically produced living larvae.
    The BioBag is presented in the five (5) configurations listed below. The larvae are Lucilia sericata contained in a sterile polyester net bag with a sterile PVA spacer cube, presented in a sterile transport container.
    BioBag 50 at least 50 larvae 25 x 40mm 1 8x8x10
    BioBag 100 at least 100 larvae 50 x 40mm 1 12x12x10
    BioBag 200 at least 200 larvae 60 x 50mm 1 25x10x10
    BioBag 300 at least 300 larvae 120 x 60mm 2 25x10x10
    BioBag 400 at least 400 larvae 100 x 100mm 2 25x10x10
    Free range larvae, larvae and 30 x 30 flat retention net plus kit pack, larvae and 40 x
    60cm boot retention net plus kit pack. Additional 100 or 200 larvae available.
    Type of wound product is suitable for
    The BioMonde Larval Debridement Therapy Products are indicated for debridement of non-healing necrotic skin and soft tissue wounds, including pressure ulcers, venous stasis ulcers, neuropathic foot ulcers, and non-healing traumatic or post-surgical wounds.
    Duration dressing remains on wound before changing and frequency of dressing change
    An application of BioBag can be left in place for up to 4 days, dependent on the
    condition of the wound. If the wound is not sufficiently debrided after 4 days, the treatment can be repeated with a fresh application of BioBag. The treatment should be stopped as soon as the wound is sufficiently debrided or if no improvement is observed after 3 or more applications. The total number of treatment cycles will depend on the characteristics of the wound, the response of the patient to LDT and the aim of the therapy. Most ulcers are completely debrided within 1 to 6 treatment cycles. If exudate production is excessive, the secondary dressing may be changed as required while leaving the BioBag undisturbed. Frequent removal of the outer dressing will also help to control the odour associated with the liquefied necrotic tissue
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Larvae should not be used in patients with known hypersensitivities to fly larvae, polyester, PVA (polyvinyl alcohol) or the components of the media on which the larvae are raised (including soya protein, yeast protein, potato starch and bovine protein) as this may result in dermatitis or more severe immunological reactions in susceptible individuals. If treatment is undertaken then these patients should be under strict medical supervision for the duration of the treatment with immediate access to care. Patients with life or limb-threatening, rapidly advancing infections should not be
    treated with as LDT may interfere with the close and frequent observation that these
    patients require.
    Should not be used as first line therapy of infected tendon and bone. These wounds
    should be treated surgically and/or with antibiotics before using LDT.
    Should not be used to treat wounds which are not directly exposed to the outside.
    Wounds should never be allowed to close over the larvae either intentionally or unintentionally.
    Should not be used on wounds with an inadequate blood supply as this ultimately reduces the ability of the wound to heal. LDT will enlarge the wound as necrotic tissue is debrided but the resulting clean wound is at risk from re-infection.
    Although some mild bleeding is common during LDT, larvae should not be used on wounds that have a tendency to bleed or wounds close to an exposed major blood vessel, especially if considered to be necrotic as this can lead to rupture of the blood vessels which could be life-threatening. If LDT is attempted, the patient must remain under strict medical supervision for the duration of the treatment.
    Should not be used on patients with an inborn or medication-induced coagulopathy or
    in patients being treated with anticoagulants. If these patients are treated with LDT, they should remain under strict medical supervision for the duration of the treatment. Should never be used in sterile body cavities.
    Should be used with caution on wounds over adjacent exposed organs or leading to a body cavity, and only under close medical supervision for the duration of the treatment. Data are not available concerning the antibiotic / antiseptic activity of maggots and therefore any infected wound should receive standard antibiotic care.
    Rationale for inclusion in formulary
    Only available larval therapy on prescription.
    Rapid debridement of chronic wounds
    Can be utilised in the community
     
       
    A5.11  Protectors and aids
    Magnide
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Application aid for closed toe stockings/ compression garments 
       
    Easy-Slide
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Application aid for open toe compression hosiery garments  
       
    LimbO Waterproof protector
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Waterproof protector, non slip latex free with a flexible seal at the opening
    Type of wound product is suitable for
    Used to keep arm, PICC, leg and foot dressings dry, can be fully submerged in water
    Rationale for inclusion in formulary
    Multiple sizing for legs and arms  
       
    Seal-Tight Wound care protector
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Waterproof protector, non slip latex free
    Type of wound product is suitable for
    Used to keep leg and foot dressings dry, can be fully submerged in water
    Rationale for inclusion in formulary
    Multiple sizing for leg including extra large limb
    No adjustments required
     
       
    A5.12  Wound irrigation
    Irripod
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Sterile sodium chloride solution
    Type of wound product is suitable for
    Wound cleansing, for topical irrigation of the eye
    Duration dressing remains on wound before changing
    As required
    Frequency of dressing change
    As required
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Single use
    External use only
    Rationale for inclusion in formulary
    Cost effective
    Cleansing of wounds
     
       
    Prontosan Wound Irrigation solution
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    See under antimicrobials

     
       
    A5.13  Emollients
    Cetraben Pump cream
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Emollient containing white soft paraffin and light liquid paraffin
    Type of wound product is suitable for
    For inflamed, dry, chapped skin
    Frequency of use
    Daily
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Allergy or hypersensitivity to any of the ingredients
    Rationale for inclusion in formulary
    Treatment of dry skin
    Dermatology approved  
       
    Dermatonics Once Heel balm
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Cream containing 25% urea
    Type of wound product is suitable for
    To moisturise dry skin on the soles of feet
    For use on adults and children over 12 years of age
    Frequency of use
    Reapply daily
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Allergy or hypersensitivity to any of the ingredients, contains beeswax and lanolin
    Not to be used on children under 12
    Rationale for inclusion in formulary
    Treatment of dry skin conditions of the foot. Dermatology approved
     
       
    Dermol 500 Lotion
    (Please note:- can only be prescribed by Independent prescribers))
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Emollient lotion containing an antimicrobial
    Type of wound product is suitable for
    For dry and pruritic skin conditions including eczema and dermatitis. Can be applied to skin as an emollient or used as a soap substitute
    Frequency of use
    Reapply daily
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Allergy or hypersensitivity to any of the ingredients, contains benzalkonium chloride,
    0.1%, chlorhexidine hydrochloride 0.1%, liquid paraffin, isopropyl myristate. Should not be used unless infection is present or is a frequent complication
    Rationale for inclusion in formulary
    Treatment of dry skin requiring antimicrobial properties
    Dermatology approved
     
       
    Liquid paraffin / white soft paraffin 50:50
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Emollient ointment containing liquid paraffin and white soft paraffin
    To assist the skin in retaining moisture
    Type of wound product is suitable for
    For use on all dry skin conditions including eczema and psoriasis
    Frequency of use
    Daily or more frequently if required
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Allergy or hypersensitivity to any of the ingredients
    Rationale for inclusion in formulary
    Treatment of dry skin conditions. Dermatology approved
     
       
    ZeroAQS cream®
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Emollient cream that occludes and moisturises the skin.
    Type of wound product is suitable for
    For external application for use as an emollient and as a skin cleanser/soap substitute
    in the management for dry skin conditions.
    Frequency of use
    Daily or more frequently if required
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Allergy or hypersensitivity to any of the ingredients
    Rationale for inclusion in formulary
    Dermatology approved
    Does not contain sodium lauryl sulphate (SLS) 
       
    Zerobase®
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Emollient ointment containing liquid paraffin, to moisturise dry or chapped skin
    Type of wound product is suitable for
    Symptomatic treatment of dry or chapped skin
    Can be used as a pre bathing emollient for dry skin to alleviate drying effects
    Frequency of use
    Daily or more frequently if required
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Allergy or hypersensitivity to any of the ingredients
    Rationale for inclusion in formulary
    Dermatology approved
     
       
    Zerocream®
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Emollient cream containing liquid paraffin and soft white paraffin, to moisturise dry skin
    Type of wound product is suitable for
    Symptomatic treatment of flaking, dry skin, sunburn, dry eczema and dry cases of
    psoriasis
    Frequency of use
    Daily or more frequently if required
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Allergy or hypersensitivity to any of the ingredients
    Rationale for inclusion in formulary
    Dermatology approved
     
       
    Zeroderm ointment
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Emollient ointment containing liquid paraffin and white soft paraffin To assist the skin in retaining moisture
    Type of wound product is suitable for
    For use on all dry skin conditions including eczema and psoriasis
    Can be used as a soap substitute/skin cleanser
    Frequency of use
    Daily or more frequently if required
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Allergy or hypersensitivity to any of the ingredients
    Rationale for inclusion in formulary
    Treatment of dry skin conditions. Dermatology approved
    Free from fragrance and colours, sodium lauryl sulphate, additives and preservatives 
       
    Zeroguent
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Rich emollient ointment containing light liquid paraffin, white soft paraffin and soya bean oil
    To assist the skin in retaining moisture
    Type of wound product is suitable for
    For use as a barrier and moisturiser for symptomatic treatment of dermatitis, ichthyosis, eczema and psoriasis
    Can be used as a pre bathing emollient for dry skin to alleviate drying effects
    Frequency of use
    Daily or more frequently if required
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Allergy or hypersensitivity to any of the ingredients
    Rationale for inclusion in formulary
    Dermatology approved
     
       
    A5.14  Soap substitutes
    Emulsifying Ointment
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Emollient ointment containing emulsifying wax, white soft paraffin and liquid paraffin
    Type of wound product is suitable for
    For treatment of dry skin conditions
    Frequency of use
    Daily
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Allergy or hypersensitivity to any of the ingredients
    Rationale for inclusion in formulary
    Treatment of dry skin
    Dermatology approved
     
       
    Epaderm ®Ointment
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Emollient ointment containing liquid paraffin, yellow soft paraffin and emulsifying wax
    Type of wound product is suitable for
    For use on all dry skin conditions and with dry or wet wrapping techniques
    Frequency of use
    Daily or more frequently if required
    Caution/contraindications
    Non listed
    Rationale for inclusion in formulary Treatment of dry skin conditions. Dermatology approved
     
       
    A5.15  Barrier preparations to top
    3M Cavilon Durable Barrier Cream
    View adult BNF View SPC online View childrens BNF
    First Choice
    Green
    Skin protectant
    Type of wound product is suitable for
    Intact skin
    As a barrier against bodily fluids, prevention of skin damage associated with incontinence
    Can be used alongside containment products
    Can be used to prevent friction to vulnerable areas of skin
    Frequency of use
    Reapply sparingly twice daily
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Do not use on infected skin
    Not be used as an emollient
    Not to be used around the peri wound
    Can increase adherence of some dressing products and therefore care should be taken when adhesive products are being used in conjunction with the cream on people with fragile skin
    Rationale for inclusion in formulary
    The only barrier cream that can be used in conjunction with containment products without blocking the absorption of the pad
    Cost effective, does not require reapplication at every episode of hygiene
     
    3M Cavilon No Sting Barrier Film Pump Spray and applicators
    View adult BNF View SPC online View childrens BNF
    First Choice
    Green
    Protective transparent barrier film
    Type of wound product is suitable for
    Superficial broken skin and abrasions
    As a barrier against bodily fluids, prevention of skin damage associated with incontinence
    Can be used alongside containment products
    Can be used to prevent friction to vulnerable areas of skin
    Can be used on superficial abrasions caused by incontinence
    Can be used to protect peri wound from exudate
    Can be used to protect against aggressive adhesive products
    Can be used to protect the skin surrounding stoma sites
    Frequency of use
    Every 72 hours
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Do not use on infected skin
    Allow product to dry before applying the containment products, dressings or clothing (30 seconds)
    Too many layers can make the area of skin feel stiff
    Can affect electrode readings in the treated area
    Rationale for inclusion in formulary
    Available in a foam applicator and spray to aid application
    Non sticky after use
    Can be used on broken areas of skin
    Cost effective, does not require reapplication at every episode of hygiene
     
    Proshield plus ®
    View adult BNF View SPC online View childrens BNF
    Second Choice
    Green
    Skin protectant
    Type of wound product is suitable for
    To treat injured skin associated with incontinence where a dressing seal cannot be achieved
    Frequency of use
    Apply at each episode of hygiene
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    External use only
    Avoid contact with eyes
    Known allergic sensitivity to any of the components
    Keep out of reach of children
    Do not apply to pressure ulcers or leg ulcers
    Not to be used as a first line barrier cream
    Not to be used to protect peri wound
    Not to be used as an emollient
    Rationale for inclusion in formulary
    For treatment of incontinence lesions where a standard dressing seal cannot be achieved
     
       
    Conotrane cream
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Barrier cream
    Type of wound product is suitable for
    Intact skin, not to be applied to a wound.
    To protect the skin from moisture, irritation and chafing.
    Frequency of use
    Application at every episode of hygiene. Apply a thin layer sparingly
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Not to be used in conjunction with containment products for incontinence due to the inclusion of liquid paraffin in the ingredients, which will repel urine/faeces back onto
    the skin.
    Any allergy to the listed ingredients
    Rationale for inclusion in formulary
    Dermatology approved
     
       
    MediHoney barrier cream
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Barrier cream containing active Medihoney.
    Helps to reduce inflammation

    Type of wound product is suitable for
    Treatment of incontinence related lesions
    Treats blistered skin
    Prevention and treatment of maceration and excoriation
    Treats candidiasis and intertrigo

    Frequency of use
    At each episode of hygiene

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Patch test before use

    Rationale for inclusion in formulary
    Suitable for neonates and children
    Treats fungal infections as well as incontinence associated lesions
    Reduces inflammation
    Can be applied to broken skin 
       
    Metanium ointment
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Barrier preparation
    Type of wound product is suitable for
    For relief of the symptoms of nappy rash
    Frequency of use
    Spread the ointment thinly so the skin texture can be clearly seen through it. Repeat at each nappy change.
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Not to be used on adults in conjunction with containment products for incontinence
    due to the inclusion of light liquid and white paraffin in the ingredients, which will repel urine/faeces back onto the skin.
    Any allergy to the listed ingredients
    Overdose is unlikely when Metanium Nappy Rash Ointment is used as instructed for treating nappy rash. However, as this product contains titanium salicylate, accidental ingestion or excessive topical application could lead to symptoms of salicylate poisoning.
    Rationale for inclusion in formulary
    Dermatology approved
     
       
    ProShield®
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Skin cleanser for use in patients with chronic diarrhoea or incontinence of urine.
    Type of wound product is suitable for
    To cleanse intact or injured skin from contamination of urine or faeces
    Frequency of use
    Apply at each episode of hygiene
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    External use only
    Avoid contact with eyes
    Known allergic sensitivity to any of the components
    Keep out of reach of children
    Rationale for inclusion in formulary
    For skin cleansing related to incontinence.
    Only skin cleanser available on drug tarrif  
       
    Sudocrem ®
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Barrier cream
    Type of wound product is suitable for
    Intact skin, not to be applied to a wound.
    To protect the skin from moisture, irritation and chafing. To protect the peri wound when utilising free range larvae
    Frequency of use
    Application at every episode of hygiene. Apply a thin layer sparingly. Remove with olive oil.
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Not to be used in conjunction with containment products for incontinence due to the inclusion of lanolin in the ingredients, which will repel urine/faeces back onto the skin. Any allergy to the listed ingredients
    Rationale for inclusion in formulary
    Dermatology approved
     
       
    Zinc and castor oil ointment
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Barrier cream
    Type of wound product is suitable for
    For relief of the symptoms of nappy rash and as a protective water resistant cream for
    dry, chapped skin
    Frequency of use
    As required, up to four times daily or at each nappy change.
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Not to be used on adults in conjunction with containment products for incontinence due to the inclusion of peanut oil in the ingredients, which will repel urine/faeces back onto the skin.
    Any allergy to the listed ingredients
    May mask x-ray images
    Rationale for inclusion in formulary
    Dermatology approved
     
       
    A5.16  Miscellaneous
    Appeel ®
    (Adhesive remover)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    available in 4 different applications
    Type of wound product is suitable for
    Adhesive dressing or appliance removal where skin stripping, loss of skin integrity and
    pain is a concern
  • Sachet– suitable for larger dressing removal
  • Wipes – ideal for adhesive around tubes
  • Foam applicator – ideal for infants or use of the face
  • Spray, single patient, multiple use product for all dressings and/or urinary sheath removal

    Frequency of use
    Use at each dressing change
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Should not be used when there is a known sensitivity to any of the ingredients
    If in doubt, patch test a small area, prior to use
    The product is flammable and should be used in a well ventilated area
    Avoid use around, flames and sources of ignition
    Rationale for inclusion in formulary
    For pain free removal of dressings where fragile skin is a concern

     
  •    
    Fludroxycortide tape
    (previously known as Haelan® tape)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Adhesive, waterproof, occlusive tape impregnated with 4mg/cm2 fludroxycortide (topical steroid)
    Type of wound product is suitable for
    Chronic overgranulation, non acute or weeping.
    Duration dressing remains on wound before changing
    Cut the tape to size. Apply for 12 hours at a time, remove and discard. Apply to clean, dry skin that is shorn of any hair.
    Frequency of dressing change
    Apply daily for 12 hours at a time. Maximum treatment time 7 days.

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Chicken pox
    Tuberculosis of the skin
    Hypersensitivity to any components in the tape (steroid fludroxycortide)
    Facial rosacea
    Acne vulgaris
    Perioral dermatitis
    Perianal and genital pruritis
    Dermatoses in infants Dermatitis napkin eruption Bacterial, viral and fungal infections
    Keep away from the eyes
    Avoid prolonged use on the face
    Not for untreated bacterial, fungal or viral skin lesions
    Rationale for inclusion in formulary
    Treatment of overgranulation
     
       
    Kerraped
    (Multi-use Boot)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
  • First consider client's own footwear options.

    A shoe to accommodate bandages and offload pressure from the front of the foot

    Type of wound product is suitable for
    Neuropathic foot ulcers or patients with bulky bandages who cannot wear their own footwear

    Duration product remains on wound before changing
    As required

    Frequency of use
    As required

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Ensure correct size is selected

    Rationale for inclusion in formulary
    Only footwear available for patients with neuropathic ulcers or bulky bandages
     
  •    
    KerraPro®
    (Pressure reducing pads)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    Silicone pads designed to redistribute pressure from bony prominences.
    Type of wound product is suitable for
    Prevention and treatment of category (Stage/Grade) 1 pressure ulcers
    Duration dressing remains on wound before changing
    As required. Check skin daily.
    Frequency of dressing change
    As required, check skin daily. Pads will last up to 3 months

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Must only be used as part of a pressure ulcer prevention programme
    Not to be used on a grade 2, 3 4, unstageable or deep tissue injury pressure ulcer unless directed by a clinical specialist
    Known sensitivity to silicone
    Do not use as a wound dressing
    Do not apply directly onto broken skin
    If skin macerates beneath, ensure the area is being checked and washed daily and consider utilising a cotton stockinette to reduce humidity
    Rationale for inclusion in formulary
    Cost effective
    Available in a large range of shapes and sizes
    Accessible pressure ulcer prevention medical device
    Reusable on the same patient for up to 3 months by washing with soap and water and thoroughly drying
     
       
    metronidazole 0.75% gel (Anabact®)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Type of wound product is suitable for
    Malodourous fungating wounds. Requires a secondary dressing

    Duration preparation remains on wound before changing
    Apply 1-2 times daily following cleansing
    Frequency of use
    1-2 times daily for a maximum of 8 weeks.
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Avoid exposure to strong sunlight or UV light
    Not to be used on a patient with known sensitivity to any components
    Avoid contact with eyes
    Not for use of any other aetiology of wound as odour control.
    Rationale for inclusion in formulary
    Odour control for fungating tumours
     
       
    Silver nitrate
    (Caustic pencil)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    NOT 1ST LINE TREATMENT
    ONLY TO BE USED IN A CLINIC SETTING OR BY A CLINICAL SPECIALIST
    Type of wound product is suitable for
    For treatment of chronic overgranulation, non acute or weeping.
    Duration product remains on wound before changing
    Apply moistened caustic pencil tip for 1-2 mins, whilst protecting the surrounding skin with soft paraffin.
    Frequency of use
    Maximum treatment: 3 applications
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Keep away from the eyes
    Not suitable for use on the face, ano-genital region or large areas
    Not for untreated bacterial, fungal or viral skin lesions
    Can cause chemical burns
    Rationale for inclusion in formulary
    Treatment of overgranulation
     
       
    A5.17  Burns/ Plastics speciality
    Jelonet®
    View adult BNF View SPC online View childrens BNF
    Formulary
    Red
    Paraffin gauze dressing
    Type of wound product is suitable for
    As a primary layer for use with Flamazine® or Flammercerium®
    Duration dressing remains on wound before changing
    24 hours
    Frequency of dressing change
    Daily- occasionally alternate day
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Allergy to any ingredients.
    Rationale for inclusion in formulary
    Cost effective primary layer
     
       
    Kerlix ®
    View adult BNF View SPC online View childrens BNF
    Formulary
    Red
    Gauze roll containing 0.2% Polyhexamethylene Biguanide (PHMB)
    Type of wound product is suitable for
    Colonised or infected wounds, with moderate to heavy exudate
    Duration dressing remains on wound before changing
    3 days
    Frequency of dressing change
    3 days
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Allergy to PHMB
    Do not use with Sodium hypochlorite ( Eusol) solutions, as this will deactivate PHM Do not apply gauze circumferentially as it has no stretch, and can become tight restricting circulation
    Rationale for inclusion in formulary
    Broad-spectrum antimicrobial agent that reduces bacterial colonization within the dressing and bacterial penetration through the dressing.
    Can be used in conjunction with Renasys Negative Pressure Therapy
     
       
    silver sulfadiazine 1% (Flamazine®)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Type of wound product is suitable for
    Partial thickness & full thickness burn injuries. Sloughy burn wounds or areas of graft loss
    Duration preparation remains on wound before changing
    24-48 hours
    Frequency of use
    Daily- occasionally alternate day
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Allergy to any ingredients.
    Not to use in pregnancy or breast feeding
    Take care if: suffer kidney or liver problems, deficiency of the enzyme known as glucose
    6- phosphate dehydrogenase. Taking tablets prescribed for epilepsy
    Rationale for inclusion in formulary
    Prevent and treat bacterial infections in burns, skin graft donor sites.
     
       
    Silver sulfadiazine 1.0g & Cerium nitrate 2.2g (Flammercerium®)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Red
    Type of wound product is suitable for
    Partial thickness & full thickness burn injuries.
    Duration preparation remains on wound before changing
    24-48 hours
    Frequency of use
    Daily- occasionally alternate day
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Allergy to any ingredients.
    Not to use in pregnancy or breast feeding, infants or babies under the age of 2 years.
    Take care if: suffer kidney or liver problems, deficiency of the enzyme known as glucose
    6- phosphate dehydrogenase. Taking tablets prescribed for epilepsy
    Rationale for inclusion in formulary
    Prevent and treat bacterial infections in burns
     
       
     ....
     Non Formulary Items
    Advadraw

    View adult BNF View SPC online View childrens BNF
    Non Formulary
    Black
    Discontinued January 2017.

    Suitable alternative is Aquacel
     
    DermaSilk

    View adult BNF View SPC online View childrens BNF
    Non Formulary
    Black
     
    DreamSkin

    View adult BNF View SPC online View childrens BNF
    Non Formulary
    Black
     
    Flivasorb

    View adult BNF View SPC online View childrens BNF
    Non Formulary
    Black

    Superabsorbent dressing
    Alternative to KerraMaxCare if patient discharged form hospital with.
    Type of wound product is suitable for
    For heavily exuding wounds
    Can be used under compression bandages
    Secondary Dressing Only
    Duration dressing remains on wound before changing
    Up to 7 days
    Frequency of dressing change
    When exudate levels determine
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Known sensitivity to any components of the dressing
    Lightly exuding wounds
    Must not be cut or torn
    Rationale for inclusion in formulary
    Management of heavily exuding wounds. Cost effective.
    Must be applied white side to the wound bed.

     
    Mepilex

    View adult BNF View SPC online View childrens BNF
    Non Formulary
    Black
    Replaced by Kliniderm®
     
    Polyfax®

    View adult BNF View SPC online View childrens BNF
    Non Formulary
    Black
    Product discontinued November 2017

    Type of wound product is suitable for
    Partial thickness facial burns & healing graft sites, infected/ colonised wounds
    Duration preparation remains on wound before changing
    2 days or 2-3 times/ day depending on injury site and type- as directed by Burns team
    Frequency of use
    2 days or 2-3 times/ day
    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Allergy to Polymixin B Sulphate or Bacitracin Zinc
    No more than 200g of Polyfax ointment per day
    Rationale for inclusion in formulary
    Prevent and treat bacterial infections in burns
     
    Silicone gel products

    View adult BNF View SPC online View childrens BNF
    Non Formulary
     
    Skinnies

    View adult BNF View SPC online View childrens BNF
    Non Formulary
    Black
     
    Tegaderm Hydrocolloid range

    View adult BNF View SPC online View childrens BNF
    Non Formulary
    Black

    Non Formulary on wound care group recommendation April 2019

     

    Hydrocolloid Range with film border

    Type of wound product is suitable for
    Low to moderate exuding, granulating or epithelising wounds
    Inner layer of hydrocolloid adhesive absorbs exudate providing higher absorbency
    Maintains odour control

    Duration dressing remains on wound before changing
    Up to 7 days

    Frequency of dressing change
    3-7 days

    Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
    Not suitable for infected wounds, full thickness burns or wounds with exposed bone, muscle or tendon, wounds at risk of maceration.
    Not for diabetic foot ulcers or ischaemic wounds
    Known product or component sensitivity

    Rationale for inclusion in formulary
    Outer barrier film protects the wound and
    Peri-wound skin from contaminants, body fluids, bacteria and viruses
    Does not contain gelatine or pectin
    Film border prevents creasing of the dressing
    Tegaderm hydrocolloid thin allows for observation of the wound

     
      
    Key
    note Notes
    Section Title Section Title (top level)
    Section Title Section Title (sub level)
    First Choice Item First Choice item
    Non Formulary Item Non Formulary section
    Restricted Drug
    Restricted Drug
    Unlicensed Drug
    Unlicensed
    Track Changes
    Display tracking information
    click to search medicines.org.uk
    Link to adult BNF
    click to search medicines.org.uk
    Link to children's BNF
    click to search medicines.org.uk
    Link to SPCs
    Cytotoxic Drug
    Cytotoxic Drug
    CD
    Controlled Drug
    High Cost Medicine
    High Cost Medicine
    Cancer Drugs Fund
    Cancer Drugs Fund
    NHSE
    NHS England
    Homecare
    Homecare
    CCG
    CCG

    Traffic Light Status Information

    Status Description

    Prescribing in children

    The APC notes that the informed use of unlicensed medicines or of licensed medicines for unlicensed applications (‘off-label’ use) is often necessary in paediatric practice.

    The APC advises GPs to consider specialist prescribing recommendations for Green and Amber medicines that are not subject to ESCAs or RICaDs in combination with the information provided in the BNFC which goes beyond that of marketing authorisations. The BNFC has been designed for rapid reference and the information presented has been carefully selected to aid decisions on prescribing.

      

    Green

    Medicines which are suitable for initiation and maintenance prescribing by primary and secondary care clinicians. These medicines should be initiated and prescribed within their licensed indications.  

    Amber

    Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing when appropriate, or initiation and maintenance of prescribing in Primary Care following recommendation from a Specialist.

    Some amber medicines require agreement with the local (internal) medicines committee prior to initiation; others may require a framework to support safe transfer and maintenance of care such as a RICaD or ESCA. The Formulary will be annotated to reflect these requirements.   

    Red

    Medicines for initiation and maintenance prescribing by Specialists only  

    Black

    Non-formulary medicines- medicines not recommended for routine primary care prescribing.  

    Grey

    Positive NICE TA and /or awaiting local clarification on place in therapy ; Please contact your Medicines Optimisation team for more information.  

    netFormulary